Our results demonstrate for the first time that selectively targeting Cx43 directly in DMD models prevents arrhythmogenesis and increases acute survival, while potentially improving long-term cardiac pathology and overall prognosis. Here, GJA1 is linked to Duchenne muscular dystrophy.